15th KUMAMOTO AIDS Seminar
 
Program
¡ October 1st,Wednesday @9:00-17:40 ¡ Poster Session
¡ October 2nd, Thursday @13:00-17:55 @October 2nd, Thursday @13:00-14:40
¡ October 3rd, Friday@ 8:30-15:10 @October 3rd, Friday @12:05-14:05

¡ October 1st, Wednesday
@Hotel Nikko Kumamoto 9:00-17:40@
8:40-9:00 Registration 
9:00-9:10 Opening Remarks Shinji Harada
[Vice-president, Kumamoto University]
Session I
9:10-9:55 k45l
Chair: Hiroaki Mitsuya
9:10-9:55 y45z
O-1-01
Michael D. Miller
Merck Research Laboratories, USA
HIV Drug Discovery: Past, Present, and Future
Session II
9:55-10:35 k40l
Chair: Shinichi Oka
9:55-10:35 y40z
O-1-02
Hiroaki Mitsuya
Kumamoto University, Japan
Development of HIV-1 Chemotheraputics in the Era of "HIV-1 To Be Defeated"
10:35-10:50 k15l
Coffee Break
Session III
10:50-12:05 k75l
Chair: Masafumi Takiguchi
10:50-11:35 y45z
O-1-03
Tomas Hanke
University of Oxford, UK
The 2nd generation conserved region mosaic vaccine against HIV-1.
11:35-12:05 y30z
O-1-04
Tetsuro Matano
NIID / Kumamoto University, Japan
Depletion of vaccine-induced CD107a- CD4+ T cells following SIV infection
12:05-13:30 k85l
Lunch
Session IV
13:30-14:05 k35l
Chair: Tetsuro Matano
13:30-14:05 y35z
O-1-05
Mark S. de Souza
Cooper Human Systems, USA
T cell dysregulation at the intestinal mucosa and peripheral blood during early acute HIV infection
Session V
14:05-14:40 k35l
Chair: Nobuo Sakaguchi
14:05-14:40 y35z
O-1-06
Yoshio Koyanagi
Kyoto University, Japan
Conflicts and benefits between primate lentiviruses and host restriction factors
Session VI
14:40-15:10 k30l
Chair: Hiroyuki Gatanaga
14:40-15:10 y30z
O-1-07
Takamasa Ueno
Kumamoto University, Japan
Impaired Nef function is associated with early control of HIV-1 viremia
15:10-15:25 k15l
Coffee Break
Session VII
15:25-16:40 k75l
Chair: Yorifumi Satou
15:25-16:10 y45z
O-1-08
Mathias Lichterfeld
Harvard Medical School, USA
Cellular reservoirs for HIV-1 long-term persistence despite antiretroviral therapy
16:10-16:40 y30z
O-1-09
Seiji Okada
Kumamoto University, Japan
HIV-1 restriction factor COMMD1 reinforces HIV-1 latent infection through IƒÈB-ƒ¿ stabilization.
Session VIII
16:40-17:10 k30l
Chair: Kazuhisa Yoshimura
16:40-17:10 y30z
O-1-10
Hiroyuki Yamamoto
NIID, Japan
In vivo determinants of SIV neutralizing antibody induction
Session IX
17:10-17:40 k30l
Chair: Shinya Suzu
17:10-17:40 y30z
O-1-11
Shuzo Matsushita
Kumamoto University, Japan
Therapeutic application of neutralizing antibodies based on the recent data on complementary and synergistic activities against a wide range of HIV-1 strains.
 
Home (Japanese)
Home (English)
Center for AIDS Research HP